Which Country is Best for IVF Abroad? 2025 Overseas IVF Destination Selection & Comparison Guide

AI Summary

Main text begins

Regarding IVF abroad, over the past decade I have consulted with thousands of families, and the most frequently asked question is, "Which country is best?" Every time I hear this question, I first ask back: How old are you? What is your AMH level? Do you have specific legal needs? What is your approximate budget range? Because discussing "the best" without considering individual circumstances is inherently unprofessional. This article does not promote any agency or report false success rates; it only clarifies the situation of the main destinations from two fundamental aspects: medical and legal.

1. Direct Answer: Choose a Country Based on Your Core Needs

The above are general directions. Below, we detail the specific situation of each country and points to note.

2. Real Differences Among Six Major Destinations

1. United States: Highest Technical Ceiling, High Cost Barrier

The United States has the most complete technical reserves and legal system in the field of assisted reproduction. If you need PGT-M (single gene disease screening) or third-party reproduction (surrogacy), the US is one of the few countries with clear laws and standardized operations. However, the cost is also straightforward: a full cycle (stimulation + egg retrieval + blastocyst culture + PGT + frozen embryo transfer) costs approximately $30,000–$50,000. If surrogacy is involved, the total cost can reach $100,000–$150,000.

Note: Laws vary significantly by state. California, New York, and Illinois are more friendly to assisted reproduction, while some central states have special regulations on the legal status of embryos. Additionally, US clinics usually do not offer package prices; medication, laboratory, and genetic counseling fees are billed separately. Be sure to confirm each item when inquiring.

2. Thailand: Cost-Effectiveness Advantage Remains, but Policies Tighten

Thailand has been the most familiar destination for domestic patients over the past decade. In 2024–2025, Thailand's policies on assisted reproduction have continued to tighten: surrogacy for foreign single men is explicitly prohibited, and stricter indications for embryo genetic screening are required. However,常规 IVF and PGT-A are still available, costing approximately ¥90,000–¥140,000 RMB (including medical and living expenses).

Thailand's biggest advantages are proximity, minimal dietary and cultural differences, and fast service response. However, note that Thai clinics have a high degree of commercialization; some institutions may over-recommend PGT or repeated transfers. It is advisable to obtain a complete examination report beforehand and have it evaluated by an independent doctor.

3. Georgia: Open Laws, but Polarized Laboratory Standards

Georgia, due to its relatively open laws regarding singles, donation, and surrogacy, coupled with moderate costs (¥80,000–¥120,000 RMB), has seen a significant increase in inquiries in recent years. However, one issue is easily overlooked: the overall level of assisted reproduction laboratories in Georgia is not as high as in the US or Japan, and some clinics have low blastocyst formation and PGT pass rates. If your ovarian reserve is already very low (AMH < 0.8 ng/mL), or you have few embryos, Georgia may not be the safest choice.

If you are considering Georgia, it is recommended to ask the clinic for embryo culture data from the past year (fertilization rate, blastocyst formation rate, PGT analyzable rate), rather than just looking at the success rates on promotional materials.

4. Japan: Meticulous Techniques, Strict Age Limits

Japanese assisted reproduction is characterized by meticulous management and strict age thresholds. Most clinics set the upper age limit for women at 43–45 years old, and some even require under 42. Japan has a strong genetic counseling team for PGT testing of single gene diseases and chromosomal translocations, but medication protocols are relatively conservative, and the number of eggs retrieved may be lower than in欧美 protocols.

Costs are around ¥150,000–¥200,000 RMB (medical costs in Japan are not high, but accommodation and living expenses are). Additionally, Japanese clinics generally require couples to visit multiple times, and the overall cycle requires 2–3 entries into the country, so time costs need to be considered.

5. Spain and Greece: Europe's Egg Donation Centers

Spain and Greece are the two most active countries for egg donation in Europe. Donor egg resources are abundant, waiting times are short (usually 2–6 months), and the legal protection of anonymity for donors and recipients is very mature. If you need donor eggs, these two countries are the top choice. In terms of cost, Greece is slightly lower than Spain; a donor egg cycle costs about ¥100,000–¥140,000 RMB.

However, if you are doing an autologous cycle (using your own eggs), the advantages of these two countries are less obvious, as laboratory scale and experience with complex cases are not as strong as in the US and Japan.

6. Czech Republic and Malaysia: Cost-Effective Choices, but with Shortcomings

The Czech Republic offers high cost-effectiveness in embryo culture and PGT-A, with cycle costs of ¥70,000–¥100,000 RMB, and laboratory standards are above average in Europe. However, Czech law has restrictions on embryo genetic screening, and PGT-M requires special approval. Malaysia has lower costs (¥60,000–¥90,000 RMB), but assisted reproduction in Malaysia is influenced by Islamic law, with specific requirements regarding marital status and embryo manipulation. Non-Muslim patients need to confirm in advance.

3. Doctor's Perspective: What Matters Most When Choosing a Country

Reproductive doctors I have worked with (including several from the US and Japan) typically evaluate the feasibility of overseas IVF according to the following priorities:

1. The patient's ovarian reserve and age — This is a hard indicator that determines the protocol and which country is suitable.
2. Whether the law covers your needs — For example, if PGT-M or third-party reproduction is needed, you must go to a country with clear laws.
3. Laboratory stability — Doctors value laboratory quality control data (e.g., blastocyst formation rate, survival rate after thawing) more than the clinic's advertised "clinical pregnancy rate."
4. Feasibility of communication and follow-up — Whether remote consultations go smoothly, whether reports can be understood, and whether subsequent transfers can be coordinated significantly impact the experience.

Doctors generally do not recommend choosing a country based solely on "success rates," because statistical methods vary greatly between countries: some calculate per transfer cycle, some per egg retrieval cycle, and some only count those under 35. Direct horizontal comparison is meaningless.

4. Four Most Easily Overlooked Details

5. Three Most Common Pitfalls

Pitfall 1: Being Attracted by "Guaranteed Success Packages"

Some overseas clinics offer "guaranteed success" packages that seem low-risk, but upon careful reading of the terms, you'll find they either require patients to be ≤ 35 years old with AMH ≥ 1.5, or define "success" as "having a transferable embryo" rather than "live birth." Moreover, once enrolled in the package, flexibility to change doctors is very limited. From a medical perspective, no clinic can truly guarantee outcomes; the so-called guaranteed success is essentially a risk transfer after actuarial calculation.

Pitfall 2: Ignoring Transfer Count and Frozen Embryo Management Fees

Many quotes include only one cycle of egg retrieval and the first transfer. Subsequent frozen embryo transfer costs, embryo storage fees, and thawing fees are calculated separately. If you have only 1–2 embryos, the impact is small; but if you have many embryos, the cumulative transfer costs may exceed the egg retrieval cost. When asking for a price, be sure to clarify: how many transfers are included? What is the annual frozen embryo fee?

Pitfall 3: Signing Up After Insufficient Remote Consultation

Some institutions have patients pay a deposit after online consultation, but the patient has no understanding of the doctor's treatment strategy or laboratory conditions. At a minimum, have a direct video communication with the attending doctor to ask: What stimulation protocol is suitable for my condition? Why? What is the blastocyst culture strategy? Is PGT performed on all embryos or selectively? If the doctor's answers are vague, consider switching to another clinic.

6. Standard Process and Timeline for Overseas IVF

Overall, from the initial consultation to the end of the transfer, the minimum time is 3–4 months. However, if PGT or intervals between frozen embryo transfers are involved, it usually takes 5–7 months. When planning your schedule, allow buffer time and do not schedule tightly around visa stay limits.

7. Costs Are Not Just About Medical Quotes

The cost of overseas IVF consists of four parts:

• Medical Fees — Stimulation medication, egg retrieval, blastocyst culture, PGT, transfer, anesthesia, lab procedures. This part varies the most between countries: USA $30,000–$50,000, Thailand ¥90,000–¥140,000 RMB, Georgia ¥80,000–¥120,000 RMB.
• Living & Travel Expenses — Flights, accommodation, meals, translation, local transport. Two round trips (stimulation + transfer) cost approximately ¥20,000–¥40,000 RMB, depending on the country's cost of living.
• Legal & Translation Fees — Contract notarization, medical record translation, visa processing, about ¥5,000–¥15,000 RMB.
• Hidden Costs — Annual frozen embryo fees, additional transfer fees, remote consultation fees, cycle cancellation fees. These are easily overlooked and should be itemized in the initial quote.

In terms of total cost, a budget under ¥100,000 RMB can consider Georgia, Malaysia, Czech Republic; ¥100,000–¥200,000 RMB can consider Thailand, Japan, Spain; over ¥200,000 RMB can cover most routine cycles in the USA.

8. Three Trends Observed Over a Decade in the Field

The biggest change in recent years is the increase in information transparency. Previously, patients mainly relied on agency recommendations; now, many people research clinic laboratory data, doctors' published papers, and even local legal precedents themselves. This is good, but it has also brought new problems: an excessive focus on rankings and success rates, while neglecting the match with one's own conditions.

The second trend is the increase in "second choices." Many people, after a failed attempt in Country A, go to Country B for consultation with complete examination data. We call this "cause review" rather than simply changing locations. The reasons for failure usually center on: unsuitable stimulation protocol, mismatch in laboratory culture conditions, or missed detection of embryo chromosomal abnormalities. When re-choosing a country, the focus should be on addressing the previous shortcomings, not just switching to a place with a higher success rate.

The third trend is the increasing impact of legal factors on decision-making. In 2025, several countries have adjusted immigration and family laws related to assisted reproduction, such as Thailand's restrictions on surrogacy for single men and Georgia's further clarification of the legal status of embryos. It is recommended to check the latest announcements from the country's Ministry of Justice or Ministry of Health before finalizing a destination, and not rely on information from 2 years ago.

9. Recommendations for Two Special Situations

Situation A: AMH Below 0.5 ng/mL

This indicates severely diminished ovarian reserve. It will be difficult to obtain a large number of eggs with any stimulation protocol in any country. Priority should be given to countries and clinics with experience in minimal stimulation, such as Japan's "mini-stimulation" or "natural cycle" protocols, or the USA's "dual stimulation" protocol. At the same time, be mentally prepared: multiple egg retrievals may be needed to accumulate enough embryos. Georgia and Thailand have relatively less clinical experience in this area and are not the first choice.

Situation B: Need for Third-Party Reproduction (Surrogacy)

Currently, the clearest legal environments are the USA (some states), Georgia, and Ukraine (though Ukraine is currently unstable due to war). The US states of California and New York have the most legal precedents for surrogacy, with standardized contracts, but costs are high (total $100,000–$150,000). Georgia has lower costs (total approximately $50,000–$70,000), but legal details are not as comprehensive as in the US; it is essential to have the contract reviewed by a local lawyer. Other countries and regions (including Thailand, Cambodia, Nepal) currently have uncertain policies regarding cross-border surrogacy and are not recommended as a first choice.

Final Words: Four Suggestions from a Doctor to Patients

This article is compiled based on public information in the assisted reproduction industry and professional experience, and does not constitute medical advice. Please consult a licensed physician for specific treatment plans. Legal policies in different countries may change at any time; please refer to the latest official information before making a decision.